It is recommended for providers to use a stroke assessment system. A System such as Cincinnati Prehospital Stroke Scale (CPSS) is a simple tool when assessing a stroke patient. CPSS Stroke Scale: Facial Droop To check: ask patient to smile Normal: patient's cheeks mov...
From FDA approvals to updated guidelines, 2024 brought transformative advancements in sleep medicine, offering new hope for managing complex sleep disorders. Crisis Point: Benzene Concerns in Acne Care ByTim Smith December 25th 2024 In this episode of Crisis Point, this year’s news regarding benzen...
Providers, in turn, are expecting more relevant messages, information and even decision support. Being able to target messages, timing and channels lets you get the most out of skilled people, and integrate digital engagement channels in ways that move the needle -- and move your business ...
Current Therapeutic Guidelines for Managing Resistant Hypertension Integration of PPAR Agonists in Treatment Landscape of PBC FCS’ Affect on Quality of Life Improving Management of Iron Deficiency, with Steven Fein, MD Updates, News in Sickle Cell Disease, with Steven Fein, MD ...
Where can durable medical equipment (DME) companies and pharmacists glean useful information about federal and state regulations and statutes and guidelines for compliant operations? Enter Health Care Providers (HCP) Institute, Amarillo, Texas, which is offering one-day, two-day, and three-day ...
Learn more about theAlpha-1Screening Guidelines Is AAT deficiency behind their COPD? Primary care providers and other allied healthcare providers are likely to be the first point of contact for patients with COPD.2Your role is vital to increasing identification and diagnosis of AAT deficiency, an...
Find out how you can partner with providers to identify the right patient for the right treatment at the right time, leading to improved patient outcomes and reduced healthcare costs. LET'S CONNECT CLINICAL DECISION SUPPORT TOOLS Improve product adoption, decrease healthcare costs, ...
Chari Cohen, DrPH, MPH: Healthcare Providers’ Role in HBV Clinical Trial Diversity Telehealth Could Address HCV Care Barriers, Expand Treatment for People Who Inject Drugs Mitchell Shiffman, MD: Phase 2b AHFIRM Data for Larsucosterol in Alcohol-Associated Hepatitis ...
symptoms, or high risk exposure suggestive of TB (eg, persistent cough, weight loss, subfebrile temperature) appear during or after ILARIS therapy. Healthcare providers should follow current CDC guidelines both to evaluate for and to treat possible latent TB infections before initiating therapy with...
(EGPA), conditions which are often treated with systemic corticosteroid therapy. These events may be associated with the reduction of oral corticosteroid therapy. Healthcare providers should be alert to vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in ...